Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA62074
Max Phase: Preclinical
Molecular Formula: C13H8O3
Molecular Weight: 212.20
Molecule Type: Small molecule
Associated Items:
ID: ALA62074
Max Phase: Preclinical
Molecular Formula: C13H8O3
Molecular Weight: 212.20
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1cc2c(o1)C(=O)c1ccccc1C2=O
Standard InChI: InChI=1S/C13H8O3/c1-7-6-10-11(14)8-4-2-3-5-9(8)12(15)13(10)16-7/h2-6H,1H3
Standard InChI Key: XUZHFXXIFCAROU-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 212.20 | Molecular Weight (Monoisotopic): 212.0473 | AlogP: 2.36 | #Rotatable Bonds: 0 |
Polar Surface Area: 47.28 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 2.18 | CX LogD: 2.18 |
Aromatic Rings: 2 | Heavy Atoms: 16 | QED Weighted: 0.57 | Np Likeness Score: 0.72 |
1. Hayashi T, Smith FT, Lee KH.. (1987) Antitumor agents. 89. Psychorubrin, a new cytotoxic naphthoquinone from Psychotria rubra and its structure-activity relationships., 30 (11): [PMID:3669007] [10.1021/jm00394a013] |
2. Goulart MO, Zani CL, Tonholo J, Freitas LR, de Abreu FC, Oliveira AB, Raslan DS, Starling S, Chiari E. (1997) Trypanocidal activity and redox potential of heterocyclic- and 2-hydroxy-naphthoquinones, 7 (15): [10.1016/S0960-894X(97)00354-5] |
3. Reichstein A, Vortherms S, Bannwitz S, Tentrop J, Prinz H, Müller K.. (2012) Synthesis and structure-activity relationships of lapacho analogues. 1. Suppression of human keratinocyte hyperproliferation by 2-substituted naphtho[2,3-b]furan-4,9-diones, activation by enzymatic one- and two-electron reduction, and intracellular generation of superoxide., 55 (16): [PMID:22845014] [10.1021/jm3009597] |
4. Patel OPS, Beteck RM, Legoabe LJ.. (2021) Antimalarial application of quinones: A recent update., 210 [PMID:33333397] [10.1016/j.ejmech.2020.113084] |
Source(1):